These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 18847553)

  • 21. [Analysis of risk factors for cervical cancer in Xiangyuan County, Shanxi Province].
    Rong S; Chen W; Wu L; Zhang X; Shen G; Liu Y; Zhao F; Ma J; Qiao Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):41-3. PubMed ID: 11955348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The carcinogenicity of human papillomavirus types reflects viral evolution.
    Schiffman M; Herrero R; Desalle R; Hildesheim A; Wacholder S; Rodriguez AC; Bratti MC; Sherman ME; Morales J; Guillen D; Alfaro M; Hutchinson M; Wright TC; Solomon D; Chen Z; Schussler J; Castle PE; Burk RD
    Virology; 2005 Jun; 337(1):76-84. PubMed ID: 15914222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High prevalence of human papillomavirus type 58 in patients with cervical pre-malignant lesions in southern Brazil.
    Paesi S; Serafini EP; Barea F; Madi SR; Echeverrigaray S
    J Med Virol; 2009 Jul; 81(7):1270-5. PubMed ID: 19475616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus testing for primary cervical cancer screening.
    Grce M; Davies P
    Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of human papillomavirus infection.
    Dillner J; Meijer CJ; von Krogh G; Horenblas S
    Scand J Urol Nephrol Suppl; 2000; (205):194-200. PubMed ID: 11144898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biology of papillomavirus II infections. Their role in the carcinogenesis of the cervix].
    Mougin C; Bernard B; Lab M
    Ann Biol Clin (Paris); 1998; 56(1):21-8. PubMed ID: 9754219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
    Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of preventive human papillomavirus vaccination.
    Lehtinen M; Paavonen J
    Int J STD AIDS; 2003 Dec; 14(12):787-92. PubMed ID: 14678583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. International correlation between human papillomavirus prevalence and cervical cancer incidence.
    Maucort-Boulch D; Franceschi S; Plummer M;
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):717-20. PubMed ID: 18349293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recommendations for cervical cancer prevention in Asia Pacific.
    Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
    Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines.
    Mendez F; Munoz N; Posso H; Molano M; Moreno V; van den Brule AJ; Ronderos M; Meijer C; Munoz A;
    J Infect Dis; 2005 Oct; 192(7):1158-65. PubMed ID: 16136457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiologic risk profile of infection with different groups of human papillomaviruses.
    Chan PK; Ho WC; Wong MC; Chang AR; Chor JS; Yu MY
    J Med Virol; 2009 Sep; 81(9):1635-44. PubMed ID: 19623668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies against human papillomavirus infection and cervical cancer.
    Jung WW; Chun T; Sul D; Hwang KW; Kang HS; Lee DJ; Han IK
    J Microbiol; 2004 Dec; 42(4):255-66. PubMed ID: 15650698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
    Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
    Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions.
    Cento V; Ciccozzi M; Ronga L; Perno CF; Ciotti M
    J Med Virol; 2009 Sep; 81(9):1627-34. PubMed ID: 19626616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor axis and oncogenic human papillomavirus natural history.
    Harris TG; Burk RD; Yu H; Minkoff H; Massad LS; Watts DH; Zhong Y; Gange S; Kaplan RC; Anastos K; Levine AM; Moxley M; Xue X; Fazzari M; Palefsky JM; Strickler HD
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):245-8. PubMed ID: 18199731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis of characteristics of women with cervical cancer in high- versus low-incidence regions.
    Liu J; Rose B; Huang X; Liao G; Carter J; Wu X; Thompson C
    Gynecol Oncol; 2004 Sep; 94(3):803-10. PubMed ID: 15350376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
    Domingo EJ; Noviani R; Noor MR; Ngelangel CA; Limpaphayom KK; Thuan TV; Louie KS; Quinn MA
    Vaccine; 2008 Aug; 26 Suppl 12():M71-9. PubMed ID: 18945416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.
    Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA
    Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study.
    Thomas JO; Herrero R; Omigbodun AA; Ojemakinde K; Ajayi IO; Fawole A; Oladepo O; Smith JS; Arslan A; Muñoz N; Snijders PJ; Meijer CJ; Franceschi S
    Br J Cancer; 2004 Feb; 90(3):638-45. PubMed ID: 14760378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.